Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name Singulex Inc. Proposed Ticker SGLX CUSIP 82933Q102 Business Description An innovative diagnostics company committed to improving patient care and enabling the reduction of healthcare costs by providing high-value, advanced tests for the diagnosis and monitoring of chronic diseases. Lead Underwriter Piper Jaffray & Co., UBS Investment Bank Co-Managers Leerink Swann LLC., William Blair and Co., L.L.C. Initial Shares 4375000 Revised Initial Shares N/A Initial Price $15.00-$17.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.